| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36bfb082efdda5e7e586209c052955f2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 |
| filingDate |
2007-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6928f4c5d4693531b5c83483e950d383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71606cd5a04dbda24b8bc27fd39d9b0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa651b8eb0d4fde7b9e7f4e614d48357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d40eefb768ca87421735fc32b707c1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_535000429510c8de6dde28fdfbbd243f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a689f873dd7ca1cf33584f9e177d725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66c57436e9333f4fc307991ad318e37d |
| publicationDate |
2008-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2913020-A1 |
| titleOfInvention |
NEW VIII FACTORS FOR THE TREATMENT OF TYPE A HEMOPHILS |
| abstract |
The present invention relates to improved variants of human FVIII having at least one substitution in the A2 and / or C2 domain. The present invention also relates to their uses for the treatment of hemophilia type A, especially in patients with inhibitors. |
| priorityDate |
2007-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |